Aperio Clinical Outcomes functions as a Contract Research Organization (CRO), providing specialized support to pharmaceutical, biotechnology, and medical device companies. They guide complex clinical trials from initial stages through completion, helping to advance new medical treatments and therapies for patients.
Core Clinical Research Services
Aperio Clinical Outcomes offers a comprehensive range of clinical research services tailored to client needs. These services span the entire lifecycle of a clinical trial, from initial setup to study closeout. Capabilities include robust data management practices, involving the design of fit-for-purpose databases and assessment of data quality risks to ensure accuracy.
The organization also provides advanced data analytics, utilizing tools such as Trial Data Intelligence (TDI™) for deeper insights. TDI™ facilitates real-time reporting from various study data sources, allowing for proactive monitoring of study, site, and clinical research associate performance. This helps identify potential issues early and visualize subject-level safety and treatment data. Aperio also offers quality assurance consulting and strategic resourcing, ensuring adherence to regulatory standards and efficient personnel allocation.
Therapeutic Area Specializations
Aperio Clinical Outcomes possesses extensive experience across numerous medical fields, managing diverse clinical trial complexities. Their specializations encompass a broad spectrum of conditions, including cardiovascular, central nervous system (CNS), dermatology, genetic diseases, immunology, infectious diseases, metabolic disorders, and various forms of oncology. This deep understanding of specific disease areas means they are well-versed in unique patient populations, disease progression, and regulatory pathways.
The organization has a strong background in oncology, having managed over 170 oncology trials across different indications and treatment modalities. This includes experience with solid tumor indications (e.g., lung, breast, and gastrointestinal cancers) and hematology oncology indications (e.g., leukemias and lymphomas). This focused expertise helps streamline trial processes, ensuring studies are designed and executed with precision to address the unique challenges of cancer research.
Operational Model and Geographic Scope
Aperio Clinical Outcomes operates with a client-focused approach, emphasizing transparent interactions and building solutions around each partner’s specific requirements. They provide honest answers and constructive feedback throughout the research process. This collaborative model integrates seamlessly with client teams, supporting them in achieving study objectives.
The organization demonstrates a wide geographic reach, supporting clinical trials across multiple continents. Their operational presence extends to North America, South America, Europe, Africa, and the Asia-Pacific (APAC) region. This global capability positions Aperio to manage studies requiring diverse patient populations and navigate varied international regulatory landscapes, supporting broad-scale clinical development programs.